--- title: "CELL MICROSYSTEMS INC — Capability Statement" uei: "G51EN7YDH7F3" cage: "61FJ8" canonical: "https://teamingindex.com/contractor/G51EN7YDH7F3/capability.md" html_url: "https://teamingindex.com/contractor/G51EN7YDH7F3" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "CELL MICROSYSTEMS INC" primary_naics: "334516" sam_status: "active" active_exclusion: false claimed: false tier: "unclaimed" --- # CELL MICROSYSTEMS INC > CELL MICROSYSTEMS INC is a SAM.gov-registered entity based in DURHAM, NC 27713-4384. UEI G51EN7YDH7F3; CAGE 61FJ8; primary NAICS 334516. Compliance posture not provided. Active SAM registration. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** CELL MICROSYSTEMS INC - **UEI (SAM.gov Unique Entity ID):** G51EN7YDH7F3 - **CAGE code:** 61FJ8 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** DE - **Website:** - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** DURHAM, NC 27713-4384 - **Country:** United States - **Congressional district:** NC-04 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 334516 | Analytical Laboratory Instrument Manufacturing | Yes | Yes | | 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | No | Yes | - **PSC codes:** None on file Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status - Small Business (SB) Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** Active SAM registration - **Registration expires:** 2027-02-03 - **Registration activated:** 2026-02-04 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $318,881 - **Award history:** 4 awards on record - **Top funding agencies:** Agricultural Research Service; Department of Veterans Affairs; Food and Drug Administration Showing all 4 awards. | Award PIID | Agency | NAICS / PSC | Obligated | Base + all options | Period of performance | Set-aside | Place of performance | Description | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 36C25624P1719 | Department of Veterans Affairs / Department of Veterans Affairs | 541990 / J066 | $102,534 | — | 2024-09-30 → 2027-09-29 | — | TX | ANNUAL SHEAR FLOW PM | | 75F40126P00109 | Department of Health and Human Services / Food and Drug Administration | 334516 / 6640 | $52,550 | — | 2026-07-06 → 2026-09-30 | — | NC | EO 14398 BIOFLUX 200+ FLEXIBLE SHEAR FLOW SYSTEM | | 12805B24P0217 | Department of Agriculture / Agricultural Research Service | 334516 / 6640 | $149,987 | — | 2024-08-06 → 2024-12-06 | — | NC | CELL MICROSYSTEMS AIR RAFT SYSTEM, TO INCLUDE INSTALLATION AND TRAINING, AND CALIBRATION ARRAY | | 75N93024P00554 | Department of Health and Human Services / National Institutes of Health | 334516 / 6640 | $13,810 | — | 2024-04-18 → 2024-07-17 | — | NC | CELL MICROSYSTEMS, INC (AMBIS \#2216308) BIOFLUX 200 WITH PLATES | ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 19 SBIR/STTR awards totaling $15.1M: SBIR Phase I 8, SBIR Phase II 6, STTR Phase I 3, STTR Phase II 2 - By agency: Department of Health and Human Services 19 - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2023, May 17, 2023 to Apr 30, 2025: Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem ($1,590,654) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2021, Aug 1, 2021 to Jul 31, 2022: Improving iPSC reprogramming and CRISPR gene editing workflows and efficacy using CellRaft technology ($256,605) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2021, Jan 1, 2021 to Dec 31, 2021: Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System ($292,047) - SBIR Phase II (Direct to Phase II), Department of Health and Human Services (National Institutes of Health), 2020, Aug 1, 2020 to Jul 31, 2022: Three-dimensional organoid culture using the CellRaft microwell technology ($1,233,851) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2020: THE THE PURPOSE OF THE PHASE II PROGRAM IS TO FOCUS ON DEVELOPING A T-CELL ACTIVATION PROTOCOL CONSISTENT WITH REPORTERCELL VIABILITY, DEVELOPING A PR ($1,648,645) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Jun 1, 2019 to May 31, 2020: Three-dimensional organoid culture using the CellRaft microwell technology ($300,161) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2019, May 1, 2019 to Apr 30, 2021: High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array ($1,633,248) - STTR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Jan 1, 2019 to Jun 30, 2020: Automated CRISPR Screening Using the CellRaft Technology ($267,489) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019: TOPIC 382 - INTEGRATED IMAGING AND MOLECULAR ANALYSIS OF GLIOBLASTOMA USING SCOPE SEQ ON THE AIR FLOW ($297,629) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2018, Dec 15, 2017 to Nov 30, 2020: Fully integrated single cell imaging and RNA-Seq library preparation ($1,544,861) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 13, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.